Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Neurodegeneration appears to be the biological mechanism most proximate to cognitive decline in Alzheimer's disease. We test whether t-tau and alternative biomarkers of neurodegeneration—neurogranin and neurofilament light protein (NFL)—add value in predicting subclinical cognitive decline.
One hundred fifty cognitively unimpaired participants r...
Alternative Titles
Full title
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_gup_ub_gu_se_281489
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_281489
Other Identifiers
ISSN
2352-8737
E-ISSN
2352-8737
DOI
10.1016/j.trci.2019.02.004
